Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Gottlieb

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
American Heart Journal|October 12, 2010
Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST])Peter Carson, Mona Fiuzat, Christopher O'Connor, et al.
Journal of Cardiac Failure|December 20, 2005
Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trialJ Jamie Caro, Kristin Migliaccio-Walle, Judith A O'Brien, et al.
Critical Care Medicine|January 15, 2013
Preoperative endogenous ouabain predicts acute kidney injury in cardiac surgery patientsElena Bignami, Nunzia Casamassima, Elena Frati, et al.
Archives of Internal Medicine|April 27, 2011
Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart diseaseAdeel A Butt, Chung-Chou Chang, Lewis Kuller, et al.
Journal of the American Heart Association|October 18, 2014
HIV infection and cardiovascular disease in womenJulie A Womack, Chung-Chou H Chang, Kaku A So-Armah, et al.
JAMA Internal Medicine|March 6, 2013
HIV infection and the risk of acute myocardial infarctionMatthew S Freiberg, Chung-Chou H Chang, Lewis H Kuller, et al.
JAMA Cardiology|April 7, 2017
Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort StudyMatthew S Freiberg, Chung-Chou H Chang, Melissa Skanderson, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
American Heart Journal|October 12, 2010
Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST])Peter Carson, Mona Fiuzat, Christopher O'Connor, et al.
Journal of Cardiac Failure|December 20, 2005
Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trialJ Jamie Caro, Kristin Migliaccio-Walle, Judith A O'Brien, et al.
Critical Care Medicine|January 15, 2013
Preoperative endogenous ouabain predicts acute kidney injury in cardiac surgery patientsElena Bignami, Nunzia Casamassima, Elena Frati, et al.
Archives of Internal Medicine|April 27, 2011
Risk of heart failure with human immunodeficiency virus in the absence of prior diagnosis of coronary heart diseaseAdeel A Butt, Chung-Chou Chang, Lewis Kuller, et al.
Journal of the American Heart Association|October 18, 2014
HIV infection and cardiovascular disease in womenJulie A Womack, Chung-Chou H Chang, Kaku A So-Armah, et al.
JAMA Internal Medicine|March 6, 2013
HIV infection and the risk of acute myocardial infarctionMatthew S Freiberg, Chung-Chou H Chang, Lewis H Kuller, et al.
JAMA Cardiology|April 7, 2017
Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort StudyMatthew S Freiberg, Chung-Chou H Chang, Melissa Skanderson, et al.
Pageof 2